The Valley Desk

NCT07085338 · Interventional trial

A Phase II Study With a Safety Run-In of the Addition of N-803 to a Chemoimmunotherapy Backbone for the Treatment of Patients With Relapsed or Refractory Neuroblastoma

Overall registry status Recruiting

Phase 2

Conditions Neuroblastoma Recurrent

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov